CollPlant to Acquire Israeli Deep-Tech Firm LightSolver
CLGN sits 40% above its 52-week low of $0.264 on elevated volume (44× avg).
Summary
CollPlant Biotechnologies announced it will acquire LightSolver, an Israeli deep-tech company. The deal marks a strategic expansion beyond CollPlant's core regenerative medicine focus. CollPlant will issue 3,734,476 shares (19.7% pre-deal), pre-funded warrants for 6,134,363 shares, and milestone warrants for up to 224,078,345 shares. A $2.0M LightSolver SAFE remains outstanding. Closing expected this week. This follows a period of significant capital activity, including a $2.6 million private placement and a reverse split approved in August. The acquisition could bring new technology and capabilities, but the immediate financial impact remains unclear. Investors will watch for further details on integration and funding.
Updated with an SEC 6-K filing · What changed
Updates
· SEC 6-K — CollPlant will issue 3,734,476 shares (19.7% pre-deal), pre-funded warrants for 6,134,363 shares, and milestone warrants for up to 224,078,345 shares. A $2.0M LightSolver SAFE remains outstanding. Closing expected this week.
At the time of this announcement, CLGN was trading at $0.37 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $6.8M. The 52-week trading range was $0.26 to $3.18. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.